Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

U.S. Standards for ‘Safe’ Limits of PFCs in Drinking Water Appear too High for Children

Published: Wednesday, May 08, 2013
Last Updated: Wednesday, May 08, 2013
Bookmark and Share
A new environmental toxicity study has found that exposure limits for perfluorinated compounds (PFCs) found in drinking water appear to be 100 to 1,000 times too high.

PFCs are chemicals widely used in manufactured products such as non-stick cookware, waterproof clothing, and fast-food packaging.

Philippe Grandjean, adjunct professor of environmental health at HSPH, and Esben Budtz-Jørgensen of the University of Copenhagen, concluded that current exposure limits do not adequately protect children and other vulnerable groups against adverse effects on the human immune system. These same researchers showed in 2012 that routine childhood vaccines are less effective in children exposed to PFCs.

The new study, “Immunotoxicity of perfluorinated alkylates: Calculation of benchmark doses based on serum concentrations in children,” was published online April 18, 2013, in the BioMed Central open access journal Environmental Health.

The researchers compared blood concentration levels of PFCs for 431 five-year-olds in a birth cohort to serum antibody concentrations against tetanus and diphtheria toxoids in the same children at age 7. A doubling in PFC exposure was associated with a 50% decrease in the antibody concentration. As a threshold for this effect could not be identified, the researchers calculated a so-called benchmark dose to identify approximate exposure levels that would protect against the effect. The same method is used by EPA and other agencies.

“Most of the research on PFCs is fairly recent. So it’s no surprise that the EPA limits are already outdated. But if they are more 100 times too high, we need to discuss what went wrong and why the limits were so far off,” Grandjean said.

According to the authors, the discrepancy between the current safe levels and the tolerable exposure levels identified in the new study has occurred because PFCs have not been subjected to systematic toxicity testing, as they were ‘grandfathered’ in when the Toxic Substances Control Act (TSCA) was enacted in the U.S. in 1976. Although production of one of the compounds studied, PFOA (or C8), is currently being phased out in the U.S. and production of another (PFOS) has stopped, exposures continue due to the persistence of these compounds in the environment and in consumer products, and their continued production in other countries.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Cancer Treatment Approach Carries Success
Researchers report that exhausted T cells are controlled by different molecular circuits than T cells effectively battling infections or cancer.
Monday, October 31, 2016
3D-Printed Heart-On-A-Chip with Integrated Sensors
Researchers have created the first 3D-printed organ-on-a-chip with integrated sensors, paving the way for more complex, customizable devices.
Tuesday, October 25, 2016
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Wednesday, October 19, 2016
A Diversity of Genomes
New DNA from understudied groups reveals modern genetic variation, ancient population shifts.
Friday, September 23, 2016
Diverse Fungi Secrete Similar Suite of Decomposition Enzymes
A recent study reveals different fungal species secrete a rich set of enzymes that share similar functions, despite species-specific differences in the amino acid sequences of these enzymes.
Tuesday, August 30, 2016
Biological Barcodes Using CRISPR
Using genome editing tools, researchers are getting closer to understand differentiation of various cell types during development.
Thursday, August 25, 2016
Toxic Chemicals Found in Drinking Water of 33 States
High levels of fluorinated compounds have been linked to cancer, hormone disruption.
Thursday, August 11, 2016
New Approach To Severe Bacterial Infections And Sepsis
Protein fragment could provide a defense when antibiotics fail.
Friday, July 08, 2016
Harvard Licenses Genotyping Platform
Novel approach aids development of drug resistance testing products for HIV.
Tuesday, May 24, 2016
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Monday, May 23, 2016
New Weapon Against Breast Cancer
Molecular marker in healthy tissue can predict a woman’s risk of getting the disease, research says.
Thursday, April 07, 2016
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Tuesday, March 22, 2016
Scaling Up Tissue Engineering
Wyss Institute has invented Bioprinting technique that creates thick 3D tissues composed of human stem cells and embedded vasculature, with potential applications in drug testing and regenerative medicine.
Tuesday, March 15, 2016
Into Thin Air
Lower oxygen intake could be used to prevent mitochondrial diseases from forming.
Tuesday, March 01, 2016
High Poverty’s Effect on Childhood Leukemia
Patients more likely to suffer early relapses, which can be harder to treat.
Thursday, February 25, 2016
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Transporting Microscopic Cargo Between Human Cells
Scientists have developed a virus-inspired delivery system for material transport between cells.
Tissue Damage Is Key for Cell Reprogramming
Researchers have shown tissue damage is important for cells to return to an embryonic state for cell reprogramming.
Metabolite Promotes Cancer Cell Transformation
Researchers have identified a metabolite that promotes cancer cell transformation and colorectal cancer spread.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Bird Flu Confirmed in the Netherlands
An outbreak of H5 avian influenza was confirmed in the Flevoland province of the Netherlands.
Pasteurised Bacterium Reduces Obesity and Diabetes
Researchers have discovered that an intestinal bacterium provides a lasting effect on the intestinal barrier.
Turning Off Asthma Attacks
Researchers discover a critical cellular “off” switch for the inflammatory immune response that causes asthma attacks.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!